Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Susan E Bates

Columbia University Irving Medical Center

United States

Research Interests

Explore related searches

Professors in United States Professors in Biostatistics Biostatistics professors in United States

Articles (21)

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Collaborators (7)

Adrian Sacher

Associate Professor

University of Toronto

CANADA

View details

John-Paul Bogers

Ghent University

BELGIUM

View details

Thomas Litman

Københavns Universitet

DENMARK

View details

Eric Van Cutsem

BELGIUM

View details

Aaron Viny

Assistant Professor of Medicine

Columbia University Irving Medical Center

UNITED STATES

View details

Daniel Santa Mina

Assistant Professor

University of Toronto

CANADA

View details

William D Figg

Senior Investigator, Lab Chief, Associate Director

National Institutes of Health

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Susan E Bates

Research Interests

Explore related searches

Articles (21)

Combined HDAC and eIF4A inhibition: A novel epigenetic therapy for pancreatic ductal adenocarcinoma

Early phase trials: the perils of nonpublication.

Best Practices for Delivering Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma

Getting the right combination to break the epigenetic code

Clinical trial results: each patient's participation should count.

CA19-9 as a Dynamic Biomarker for Continuous Monitoring of Therapeutic Efficacy in Pancreatic Adenocarcinoma

<i>The Oncologist</i> turns thirty

<i>g</i>-Rate-based machine learning model to predict overall survival (OS) in patients with metastatic prostate cancer (mPC) while on treatment.

A phase 0, window of opportunity study of parasympathetic stimulation with bethanechol in localized pancreatic adenocarcinoma prior to surgery

Abiraterone vs Enzalutamide Among US Veterans With Metastatic Hormone-Sensitive Prostate Cancer

Cancer interception during treatment: using growth kinetics to create a continuous variable for assessing disease response

Comparison of PSA-based <i>g</i>-rate and conventional PSA metrics in veterans with metastatic prostate cancer (mPC).

Correlation between tumor growth rate and survival in patients with metastatic breast cancer treated with trastuzumab deruxtecan

Cutaneous T-Cell Lymphoma: Yin-Yang Effects of Transcription Factors HLF and NFIL3 in Regulation of Malignant T-Cell Markers in the Context of HDAC Inhibitor Romidepsin Treatment

Development of g-rate based random forest machine learning model to predict overall survival for patients with metastatic prostate cancer

From dimensions through dynamics to outcomes - lymph nodes and skin assessments predict CTCL outcomes

HDAC inhibitors: Cardiotoxicity and paradoxical cardioprotective effect in ischemia-reperfusion myocardiocyte injury

Highlights of ASCO 2025

Regarding RECIST in retrospective studies

Romidepsin and mogamulizumab sequential treatment for advanced cutaneous T-cell lymphoma

The Impact of Exuberance on Equipoise in Oncology Clinical Trials: Sotorasib as Archetype

Collaborators (7)

Adrian Sacher

John-Paul Bogers

Thomas Litman

Eric Van Cutsem

Aaron Viny

Daniel Santa Mina

William D Figg

Make your next move.